Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Acyclovir Cream, 5% (USRLD: Zovirax Cream). Acyclovir belongs to a class of medications known as antivirals. Acyclovir cream is used to treat cold sores (fever blisters; blisters that are caused by a virus called herpes simplex) on the face or lips. The product will be launched shortly in the US market. The drug will be manufactured at the group’s topical manufacturing facility at Changodar, Ahmedabad (India).
Acyclovir Cream, 5% had annual sales of $16.9 million in the United States (IQVIA MAT Dec. 2022). The group now has 348 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.
